← Open Payments lookup

JAN ALTISER: Open Payments

NPI 1336478601 · TRENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,009 in 50 payments from 10 companies in 2025. Trend: 2023 $771 · 2024 $1,003 · 2025 $1,009

Food & beverage: $1,009
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.7$174
E.R. Squibb & Sons, L.L.C.10$169
Otsuka America Pharmaceutical, Inc.12$165
Alkermes, Inc.6$151
Neurocrine BioSciences, Inc.5$149
Janssen Pharmaceuticals, Inc2$55
Lundbeck LLC2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
ABBVIE INC.2$32
Teva Pharmaceuticals USA, Inc.2$32

Products named: COBENFY, INGREZZA, ARISTADA, FANAPT, REXULTI, ABILIFY ASIMTUFII, INVEGA SUSTENNA, HETLIOZ.

Industry payments across MO — which companies pay providers there.